维普中文期刊产品整合服务
117篇 您的检索式:作者名="Baxevanis"
    题名 作者 年代 出处 被引量
1Immunobiology of HER2/ neu oncoprotein and its potential application in cancer immunotherapy显示文摘Baxevanis CN 2004Cancer Immunol Immunother2004,53,:1
2Enhancement of human T lymphocyte function by prothymosin alpha: increased production of IL-2 and expression of IL-2 receptors on normal human peripheral blood T lymphocytes显示文摘Baxevanis CN Frillingos S Reclos GJ 1990Immunopharmacol Immunotoxicol1990,12,:1
3Immunogenic HER-2/neu peptides as tumor vaccines显示文摘Baxevanis C N Sotiriadou N N Gritzapis A D 2006Cancer Immunol Immunother2006,55,1:1
4Mechanism of action of prothymosin alpha in the human autologous mixed lymphocyte response显示文摘Baxevanis CN Reclos GJ Economou M 1988Immunopharmacol Immunotoxicol1988,10,:1
5Immunobiology of HER2/neu oncoprotein and its potential application in cancer immunotherapy 显示文摘Baxevanis CN Sotiropoulou PA Sotiriadou NN 2004Cancer Immunol Immunother2004,53,3:1
6Molecular evolu- tion of the homeodomain family of transcription factors 显示文摘BANERJEE-BASU S BAXEVANIS A D 2001Nucl Acids Res2001,29,15:1
7Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumors显示文摘Panagiota A. Sotiropoulou Sonia A. Perez Volfgang Voelter Hartmut Echner Ioannis Missitzis Nick B. Tsavaris Michael Papamichail Constantin N. Baxevanis 2003Cancer Immunology Immunotherapy2003,,12:1
8Compromised antitumor responses in tumor necrosis factor-alpha knockout mice显示文摘Baxevanis CN Voutsas IF Tsitsilonis OE 2000Eur J Immunol2000,30,7:1
9The prognostic significance of immune changes in padents with renal cancer,mclanonla and colorectal cancer,treated with interferon alpha 2b显示文摘Tsavaris N Baxevanis C Kosmidis P 1996Cancer Immunol Immunother1996,43,2:1
10Combinatorial treatments including vaccines,chemotherapy and monoclonal antibodies for cancer therapy显示文摘Baxevanis C N Perez S A Papamichail M 0,,:1
11Induction of tumor-specific T lymphocyte responses in vivo by prothymosin alpha 显示文摘Baxevanis C N Gritzapis A D Spanakos G 1995Cancer Immunol Immunother1995,40,6:1
12Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer显示文摘Baxevanis CN Dedoussis GV Papadopoulos NG 1994Cancer1994,74,4:1
13Combinatorial treatments including vaccines,chemotherapy and monoclonal antibodies for cancer therapy显示文摘Baxevanis CN SA Perez M Papamichail 0,,03:1
14Immunogenic HER-2/neu peptides as tumor vaccines 显示文摘Baxevanis CN Sotiriadou NN Gritzapis AD 2006Cancer Immunol Immunother2006,55,1:1
15Optimization of the diaphragm forming process with regard to product quality and cost 显示文摘Pantelakis S G Baxevani E A 2002Composites Part A : Applied Science and Manufacturing2002,33,4:1
16Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy显示文摘Baxevanis CN Sotiropoulou PA Sotiriadou NN 2004Cancer Immunol Immunother2004,53,3:1
17Molecular phylogenetics and asexuality in the brine shrimp Artemia显示文摘Baxevanis A D Kappas I Abatzopoulos T J 2006Mol Phylogenet Evol2006,40,3:1
18Immunogenic HER-2/neu peptides as tumor vaccines 显示文摘Baxevanis CN Sotiriadou NN Gritzapis AD 2006Cancer Immunol Im- munother2006,55,1:1
19Modelling precipitation in Sweden using multiple step Markov chains and a composite model 显示文摘Lennartsson J Baxevani A Chen D 2008Journal of Hydrology2008,363,:1
20Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy显示文摘Baxevanis CN Sotiropoulou PA Sotiriadou NN 2004Cancer Immunol Immunother2004,53,3:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费